1、As filed with the Securities and Exchange Commission on February 28,2013UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549FORM 10-K(MARK ONE)Annual Report Pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934For the Fiscal Year Ended December 31,2012orTransition Repo
2、rt Pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934For the transition period fromtoCommission File No.1-6571Merck&Co.,Inc.One Merck DriveWhitehouse Station,N.J.08889-0100(908)423-1000Incorporated in New JerseyI.R.S.EmployerIdentification No.22-1918501Securities Registered pursua
3、nt to Section 12(b)of the Act:Title of Each ClassName of Each Exchangeon which RegisteredCommon Stock($0.50 par value)New York Stock ExchangeNumber of shares of Common Stock($0.50 par value)outstanding as of January 31,2013:3,022,367,538.Aggregate market value of Common Stock($0.50 par value)held by
4、 non-affiliates on June 30,2012 based on closing price on June 30,2012:$126,837,000,000.Indicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the SecuritiesAct.Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Sec
5、tion 13 or Section 15(d)of theAct.Yes No Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the SecuritiesExchange Act of 1934 during the preceding 12 months(or for such shorter period that the registrant was required to file such repo
6、rts),and(2)hasbeen subject to such filing requirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site,if any,every InteractiveData File required to be submitted and posted pursuant to Rule 405 of Regulation